Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0139
+0.0001 (0.87%)
At close: Nov 20, 2025
Petros Pharmaceuticals Market Cap
Petros Pharmaceuticals has a market cap or net worth of $587.28 thousand as of November 20, 2025. Its market cap has decreased by -81.75% in one year.
Market Cap
587.28K
Enterprise Value
-5.48M
Revenue
5.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from 38.73M to 587.28K, a decrease of -98.48%. That is a compound annual growth rate of -56.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 587.28K | -85.11% |
| Dec 31, 2024 | 3.94M | 27.11% |
| Dec 29, 2023 | 3.10M | -35.68% |
| Dec 30, 2022 | 4.82M | -92.98% |
| Dec 31, 2021 | 68.71M | 60.87% |
| Dec 31, 2020 | 42.71M | 10.27% |
| Dec 2, 2020 | 38.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Elite Pharmaceuticals | 621.43M |
| Glass House Brands | 426.07M |
| American Oncology Network | 412.69M |
| Tian'an Technology Group | 385.99M |
| CytoDyn | 372.76M |
| Northwest Biotherapeutics | 365.45M |
| Silence Therapeutics | 318.83M |